Position in HIMS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$38,275
+$38,275 QoQ
Shares Held
1,104
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#396
of 504 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Jun 30, 2026CallValue
$561,654
CallShares
16,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $1,494,127 across 6 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (2.6% of the industry book) .
All Filings in HIMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,275 | 1,104 | Shares | Sole | 2026-07-31 | |
| 2026-06-30 | $561,654 | 16,200 | Call | Sole | 2026-07-31 | |
| 2025-12-31 | $418,863 | 12,900 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $465,104 | 8,200 | Call | Sole | 2025-11-12 | |
| 2025-09-30 | $174,470 | 3,076 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $309,070 | 6,200 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $31,156 | 625 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $177,300 | 6,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $79,489 | 2,690 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||